Martin Enserink. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AfricaAnimalsAntimalarials/economicsAntimalarials/supply & distributionAntimalarials/therapeutic useArtemisinins/economicsArtemisinins/supply & distributionArtemisinins/therapeutic useClinical Trials as TopicDrug CostsDrug DesignDrug Evaluation, PreclinicalDrug ResistanceDrug Therapy, CombinationDrug UtilizationGenetic EngineeringHeterocyclic Compounds, 1-Ring/chemistryHeterocyclic Compounds, 1-Ring/pharmacologyHumansMalaria/drug therapyPeroxides/chemistryPeroxides/pharmacologyPlasmodium falciparum/drug effectsSpiro Compounds/chemistrySpiro Compounds/pharmacologyWorld Health Organization
Substances: See more » AntimalarialsArtemisininsHeterocyclic Compounds, 1-RingPeroxidesSpiro Compoundsarterolane
Year: 2005 PMID: 15637249 DOI: 10.1126/science.307.5706.33
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728